Treatment of Symptomatic Vitreomacular Adhesion with Expansile Sulfur Hexafluoride (SF6) Gas.

CONCLUSION: Due to its low cost, wide availability, and apparent efficacy, intravitreal injection of expansile SF6 should be investigated further as a possible treatment modality for sVMA.
PMID: 28553425 [PubMed - in process]

Source: Open Ophthalmology Journal - May 30, 2017 Category: Opthalmology Tags: Open Ophthalmol J Source Type: research